Bayesian Capital Management LP Purchases New Position in Trupanion, Inc. (NASDAQ:TRUP)

Bayesian Capital Management LP acquired a new position in Trupanion, Inc. (NASDAQ:TRUP) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,149 shares of the financial services provider’s stock, valued at approximately $253,000.

A number of other hedge funds have also bought and sold shares of TRUP. Vanguard Group Inc. boosted its holdings in shares of Trupanion by 0.9% in the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after acquiring an additional 32,485 shares during the period. Wellington Management Group LLP increased its position in shares of Trupanion by 34.6% during the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after buying an additional 630,155 shares during the period. Sivia Capital Partners LLC bought a new stake in shares of Trupanion during the fourth quarter valued at about $31,398,000. 8 Knots Management LLC purchased a new stake in shares of Trupanion in the fourth quarter worth about $21,165,000. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Trupanion by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 300,029 shares of the financial services provider’s stock valued at $9,154,000 after acquiring an additional 7,088 shares during the period.

Trupanion Stock Performance

NASDAQ TRUP opened at $37.06 on Thursday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.62 and a current ratio of 1.62. The stock’s 50-day simple moving average is $30.09 and its two-hundred day simple moving average is $27.87. Trupanion, Inc. has a twelve month low of $19.14 and a twelve month high of $38.14.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. The company had revenue of $306.12 million for the quarter, compared to analysts’ expectations of $300.51 million. Trupanion had a negative return on equity of 9.03% and a negative net margin of 2.31%. Trupanion’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the firm posted ($0.60) EPS. As a group, equities research analysts predict that Trupanion, Inc. will post -0.4 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other news, SVP Emily Dreyer sold 3,125 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $25.34, for a total value of $79,187.50. Following the completion of the sale, the senior vice president now owns 19,830 shares of the company’s stock, valued at approximately $502,492.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Melissa Joy Hewitt sold 1,200 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $30.04, for a total transaction of $36,048.00. Following the transaction, the insider now directly owns 6,105 shares in the company, valued at approximately $183,394.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Emily Dreyer sold 3,125 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $25.34, for a total value of $79,187.50. Following the completion of the sale, the senior vice president now owns 19,830 shares of the company’s stock, valued at approximately $502,492.20. The disclosure for this sale can be found here. Insiders have sold 5,325 shares of company stock worth $144,586 over the last ninety days. Insiders own 5.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on TRUP shares. Bank of America raised shares of Trupanion from a “neutral” rating to a “buy” rating and upped their target price for the stock from $35.00 to $49.00 in a report on Thursday, May 16th. William Blair started coverage on Trupanion in a research report on Friday, July 19th. They issued an “outperform” rating on the stock. Piper Sandler boosted their target price on Trupanion from $22.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, June 28th. Finally, Canaccord Genuity Group lowered their price target on Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $34.40.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.